Compare Torrent Pharma with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TORRENT PHARMA DR. REDDYS LAB TORRENT PHARMA/
DR. REDDYS LAB
 
P/E (TTM) x 42.7 39.9 107.1% View Chart
P/BV x 9.3 4.3 215.8% View Chart
Dividend Yield % 1.1 0.6 197.9%  

Financials

 TORRENT PHARMA   DR. REDDYS LAB
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-21
DR. REDDYS LAB
Mar-21
TORRENT PHARMA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs3,0405,515 55.1%   
Low Rs1,9333,028 63.9%   
Sales per share (Unadj.) Rs473.01,145.4 41.3%  
Earnings per share (Unadj.) Rs74.0114.5 64.6%  
Cash flow per share (Unadj.) Rs112.9188.4 59.9%  
Dividends per share (Unadj.) Rs35.0025.00 140.0%  
Avg Dividend yield %1.40.6 240.5%  
Book value per share (Unadj.) Rs344.91,053.2 32.8%  
Shares outstanding (eoy) m169.22166.30 101.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x5.33.7 141.0%   
Avg P/E ratio x33.637.3 90.1%  
P/CF ratio (eoy) x22.022.7 97.2%  
Price / Book Value ratio x7.24.1 177.8%  
Dividend payout %47.321.8 216.6%   
Avg Mkt Cap Rs m420,798710,289 59.2%   
No. of employees `000NANA-   
Total wages/salary Rs m14,39636,299 39.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m80,048190,475 42.0%  
Other income Rs m7572,914 26.0%   
Total revenues Rs m80,806193,389 41.8%   
Gross profit Rs m24,66638,699 63.7%  
Depreciation Rs m6,57812,288 53.5%   
Interest Rs m3,583970 369.4%   
Profit before tax Rs m15,26328,355 53.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,7449,319 29.4%   
Profit after tax Rs m12,51919,036 65.8%  
Gross profit margin %30.820.3 151.7%  
Effective tax rate %18.032.9 54.7%   
Net profit margin %15.610.0 156.5%  
BALANCE SHEET DATA
Current assets Rs m55,232145,503 38.0%   
Current liabilities Rs m48,91681,038 60.4%   
Net working cap to sales %7.933.8 23.3%  
Current ratio x1.11.8 62.9%  
Inventory Days Days1461 23.4%  
Debtors Days Days795 7.3%  
Net fixed assets Rs m81,298109,979 73.9%   
Share capital Rs m846832 101.7%   
"Free" reserves Rs m57,526174,319 33.0%   
Net worth Rs m58,372175,151 33.3%   
Long term debt Rs m29,6336,299 470.4%   
Total assets Rs m136,530255,482 53.4%  
Interest coverage x5.330.2 17.4%   
Debt to equity ratio x0.50 1,411.6%  
Sales to assets ratio x0.60.7 78.6%   
Return on assets %11.87.8 150.6%  
Return on equity %21.410.9 197.3%  
Return on capital %21.416.2 132.5%  
Exports to sales %051.3 0.0%   
Imports to sales %018.1 0.0%   
Exports (fob) Rs mNA97,699 0.0%   
Imports (cif) Rs mNA34,420 0.0%   
Fx inflow Rs m21,53997,699 22.0%   
Fx outflow Rs m7,13634,420 20.7%   
Net fx Rs m14,40363,279 22.8%   
CASH FLOW
From Operations Rs m20,10735,703 56.3%  
From Investments Rs m-4,494-22,660 19.8%  
From Financial Activity Rs m-16,561-298 5,557.5%  
Net Cashflow Rs m-89312,858 -6.9%  

Share Holding

Indian Promoters % 71.3 26.7 266.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 20.6 49.2 41.8%  
FIIs % 11.6 27.8 41.9%  
ADR/GDR % 0.0 12.1 -  
Free float % 28.8 61.2 46.9%  
Shareholders   67,205 255,720 26.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TORRENT PHARMA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    CADILA HEALTHCARE    



Today's Market

Sensex Recovers After Plunging 800 Points, Nifty Trades Near 17,650; Tech Mahindra, Bajaj Finserv Top Losers(10:30 am)

Asian stock markets plunged today after US stocks took a beating, hurt by lingering concerns over the Federal Reserve's tightening and weaker-than-expected economic and earnings data.

Related Views on News

Torrent Pharma Beats Expectations: Stock Gets a Boost (Views On News)

May 19, 2021

Key takeaways from Torrent Pharma's March quarter results.

Dr Reddy's New Covid-19 Treatment Option Puts Stock in Focus (Views On News)

May 24, 2021

With the second wave pushing up sales of medicines, Indian pharma companies are likely to see traction in their volumes.

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

More Views on News

Most Popular

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Jan 21, 2022 01:01 PM

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 5-YR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS